Research Summary
The pneumococcal vaccine is a preventive immunization designed to protect against infections caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is a major cause of serious respiratory illnesses, such as pneumonia, meningitis, and septicemia, particularly in young children, the elderly, and individuals with weakened immune systems. The pneumococcal vaccine stimulates the immune system to produce antibodies against specific strains of the bacterium, reducing the likelihood of infection and its potentially severe complications. There are different types of pneumococcal vaccines, including conjugate and polysaccharide vaccines, each targeting various age groups and offering protection against a range of pneumococcal strains. The vaccine is a vital component of routine immunization schedules globally, contributing significantly to the prevention of pneumococcal diseases and their associated morbidity and mortality.
According to DIResearch's in-depth investigation and research, the global Pneumococcal Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur, CDIBP etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Pneumococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pneumococcal Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pneumococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pneumococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pneumococcal Vaccine Include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Pneumococcal Vaccine Product Segment Include:
PPSV 23
PCV 7/13
PCV 10
Pneumococcal Vaccine Product Application Include:
Child
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Pneumococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Pneumococcal Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Pneumococcal Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Pneumococcal Vaccine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Pneumococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Pneumococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Pneumococcal Vaccine Market Overview 1.1 Product Definition and Statistical Scope 1.2 Pneumococcal Vaccine Product by Type 1.2.1 Global Pneumococcal Vaccine Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 PPSV 23 1.2.3 PCV 7/13 1.2.4 PCV 10 1.3 Pneumococcal Vaccine Product by Application 1.3.1 Global Pneumococcal Vaccine Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Child 1.3.3 Adult 1.4 Global Pneumococcal Vaccine Market Revenue and Sales Analysis 1.4.1 Global Pneumococcal Vaccine Market Size Analysis (2019-2030) 1.4.2 Global Pneumococcal Vaccine Market Sales Analysis (2019-2030) 1.4.3 Global Pneumococcal Vaccine Market Sales Price Trend Analysis (2019-2030) 1.5 Pneumococcal Vaccine Market Development Status and Trends 1.5.1 Pneumococcal Vaccine Industry Development Status Analysis 1.5.2 Pneumococcal Vaccine Industry Development Trends Analysis 2 Pneumococcal Vaccine Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Pneumococcal Vaccine Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Pneumococcal Vaccine Market Analysis by Regions 4.1 Pneumococcal Vaccine Overall Market: 2023 VS 2024 VS 2030 4.2 Global Pneumococcal Vaccine Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Pneumococcal Vaccine Revenue and Market Share by Region (2019-2024) 4.2.2 Global Pneumococcal Vaccine Revenue Forecast by Region (2025-2030) 4.3 Global Pneumococcal Vaccine Sales and Forecast Analysis (2019-2030) 4.3.1 Global Pneumococcal Vaccine Sales and Market Share by Region (2019-2024) 4.3.2 Global Pneumococcal Vaccine Sales Forecast by Region (2025-2030) 4.4 Global Pneumococcal Vaccine Sales Price Trend Analysis (2019-2030) 5 Global Pneumococcal Vaccine Market Size by Type and Application 5.1 Global Pneumococcal Vaccine Market Size by Type 5.1.1 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Pneumococcal Vaccine Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Pneumococcal Vaccine Market Size by Application 5.2.1 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Pneumococcal Vaccine Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Pneumococcal Vaccine Market Size by Type 6.3.1 North America Pneumococcal Vaccine Sales by Type (2019-2030) 6.3.2 North America Pneumococcal Vaccine Revenue by Type (2019-2030) 6.4 North America Pneumococcal Vaccine Market Size by Application 6.4.1 North America Pneumococcal Vaccine Sales by Application (2019-2030) 6.4.2 North America Pneumococcal Vaccine Revenue by Application (2019-2030) 6.5 North America Pneumococcal Vaccine Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Pneumococcal Vaccine Market Size by Type 7.3.1 Europe Pneumococcal Vaccine Sales by Type (2019-2030) 7.3.2 Europe Pneumococcal Vaccine Revenue by Type (2019-2030) 7.4 Europe Pneumococcal Vaccine Market Size by Application 7.4.1 Europe Pneumococcal Vaccine Sales by Application (2019-2030) 7.4.2 ? Europe Pneumococcal Vaccine Revenue by Application (2019-2030) 7.5 Europe Pneumococcal Vaccine Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Pneumococcal Vaccine Market Size by Type 8.3.1 China Pneumococcal Vaccine Sales by Type (2019-2030) 8.3.2 China Pneumococcal Vaccine Revenue by Type (2019-2030) 8.4 China Pneumococcal Vaccine Market Size by Application 8.4.1 China Pneumococcal Vaccine Sales by Application (2019-2030) 8.4.2 China Pneumococcal Vaccine Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Pneumococcal Vaccine Market Size by Type 9.3.1 APAC (excl. China) Pneumococcal Vaccine Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Pneumococcal Vaccine Revenue by Type (2019-2030) 9.4 APAC (excl. China) Pneumococcal Vaccine Market Size by Application 9.4.1 APAC (excl. China) Pneumococcal Vaccine Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Pneumococcal Vaccine Revenue by Application (2019-2030) 9.5 APAC (excl. China) Pneumococcal Vaccine Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Pneumococcal Vaccine Market Size by Type 10.3.1 Latin America Pneumococcal Vaccine Sales by Type (2019-2030) 10.3.2 Latin America Pneumococcal Vaccine Revenue by Type (2019-2030) 10.4 Latin America Pneumococcal Vaccine Market Size by Application 10.4.1 Latin America Pneumococcal Vaccine Sales by Application (2019-2030) 10.4.2 Latin America Pneumococcal Vaccine Revenue by Application (2019-2030) 10.5 Latin America Pneumococcal Vaccine Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Pneumococcal Vaccine Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Pneumococcal Vaccine Market Size by Type 11.3.1 Middle East & Africa Pneumococcal Vaccine Sales by Type (2019-2030) 11.3.2 Middle East & Africa Pneumococcal Vaccine Revenue by Type (2019-2030) 11.4 Middle East & Africa Pneumococcal Vaccine Market Size by Application 11.4.1 Middle East & Africa Pneumococcal Vaccine Sales by Application (2019-2030) 11.4.2 Middle East & Africa Pneumococcal Vaccine Revenue by Application (2019-2030) 11.5 Middle East & Africa Pneumococcal Vaccine Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Pneumococcal Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Pneumococcal Vaccine Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Pneumococcal Vaccine Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Pneumococcal Vaccine Average Sales Price by Manufacturers (2020-2024) 12.2 Pneumococcal Vaccine Competitive Landscape Analysis and Market Dynamic 12.2.1 Pneumococcal Vaccine Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Pfizer 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Pfizer Pneumococcal Vaccine Product Portfolio 13.1.3 Pfizer Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 GSK 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 GSK Pneumococcal Vaccine Product Portfolio 13.2.3 GSK Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 MSD 13.3.1 MSD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 MSD Pneumococcal Vaccine Product Portfolio 13.3.3 MSD Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Sanofipasteur 13.4.1 Sanofipasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolio 13.4.3 Sanofipasteur Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 CDIBP 13.5.1 CDIBP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 CDIBP Pneumococcal Vaccine Product Portfolio 13.5.3 CDIBP Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Pneumococcal Vaccine Industry Chain Analysis 14.2 Pneumococcal Vaccine Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Pneumococcal Vaccine Typical Downstream Customers 14.4 Pneumococcal Vaccine Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support